Inolife (BTGN) 10-Q/A 18 Aug 14 2014 Q2 Quarterly report (amended) Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Sep. 30, 2013	Aug. 15, 2014
Document And Entity Information	'	'
Entity Registrant Name	'INOLIFE TECHNOLOGIES, INC.	'
Entity Central Index Key	'0001297965	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-13	'
Amendment Flag	'true	'
Amendment Description	'	'
	This Amendment No. 1 on Form 10-Q/A amends and restates the quarterly report on Form 10-Q of InoLife Technologies, Inc., or “the Company”, for the quarter ended September 30, 2013, as originally filed with the Securities and Exchange Commission, or “the SEC”, on January 9, 2014, and as amended on May 19, 2014. We refer to the quarterly report on Form 10-Q that was filed on January 9, 2014 as “the original filing”. Contrary to the rules of the SEC, the Company's  condensed consolidated financial statements included in the original filing and this filing have not been reviewed by an independent public accountant in accordance with professional standards for conducting such reviews.  The Company has engaged a new independent audit firm who has not yet completed their review of the financial statements.
	This amended report does not reflect any other events occurring after the original filing.
Current Fiscal Year End Date	'--03-31	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'No	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	470,319,652
Document Fiscal Period Focus	'Q2	'
Document Fiscal Year Focus	'2014	'

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2013	Sep. 30, 2013
		As Restated [Member]
Current Assets:	'	'
Cash and cash equivalents	'	$5,000
Prepaid Expenses	53,750	'
Total Current Assets	53,750	5,000
TOTAL ASSETS	53,750	5,000
Current Liabilities:	'	'
Accounts payable	766,640	787,675
Accrued management fees, related party	372,085	664,085
Accrued consulting fees	62,500	27,700
Accrued Employer taxes	84,442	95,513
Accrued interest	146,543	168,647
Convertible notes payable	585,830	591,335
Derivative Liability	365,344	228,000
Note payable, related party	64,161	78,958
Total Current Liabilities	2,447,545	2,641,913
TOTAL LIABILITIES	2,447,545	2,641,913
Commitments and Contingencies	'	'
Stockholders' Deficit	'	'
Preferred stock: 100,000,000 authorized; $0.00001 par value 132,774 and 213,322 issued and outstanding, respectively	2	2
Preferred Stock - Series C, par value $0.01 per share, 572 and -572- issued and outstanding, respectively	6	6
Common stock: 5,000,000,000 authorized; $0.00001 par value 220,080,492 and 40,040,492 issued and outstanding, respectively	400	1,485
Additional paid in capital	5,338,645	7,244,610
Accumulated deficit	-7,732,848	-9,883,016
Total Shareholders' Deficit	-2,393,795	-2,636,913
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICT)	$53,750	$5,000

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 31, 2013	Sep. 30, 2013
		As Restated [Member]
Stockholders' Deficit	'	'
Preferred stock par value	$0.00	$0.00
Preferred stock Authorized	100,000,000	100,000,000
Preferred stock Issued	213,322	132,774
Preferred stock series outstanding	213,322	132,774
Preferred stock series C, par value	$0.01	$0.01
Preferred stock series C, Issued	572	572
Preferred stock series C, shares, outstanding	572	572
Common stock, par value	$0.00	$0.00
Common stock, Authorized	5,000,000,000	5,000,000,000
Common stock, Issued	40,040,492	220,080,492
Common stock shares, outstanding	40,040,492	220,080,492

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (As Restated [Member], USD $)	3 Months Ended		6 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
As Restated [Member]	'	'	'	'
Revenues	'	'	'	'
Operating expenses	'	'	'	'
Professional fees	24,095	147,458	1,924,902	173,102
Management expenses	146,000	9,200,868	292,000	9,446,835
Selling, general and administrative expense	8,282	17,543	37,751	41,595
Total operating expenses	178,377	9,365,869	2,254,653	9,661,532
Net loss from operations	-178,377	-9,365,869	-2,254,653	-9,661,532
Other income (expenses)	'	'	'	'
Interest expense	-35,902	-47,957	-58,827	-105,148
Gain on debt forgiveness	'	'	11,757	'
Other Income	14,211	'	14,211	'
Change in fair value of derivative	'	27,479	137,344	27,479
Total other income (expenses)	-21,691	-20,478	104,485	-77,669
Loss before provision for taxes	-200,068	-9,386,347	-2,150,168	-9,739,201
Provision for income taxes	'	'	'	'
Net loss	($200,068)	($9,386,347)	($2,150,168)	($9,739,201)
Basic and diluted loss per share	$0	($6,020.39)	($0.01)	($21,405.91)
Weighted average number of shares outstanding	158,367,451	1,559	165,008,930	455

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
SUPPLEMENTAL CASH FLOW INFORMATION:	'	'
Common Stock issued for services	18,040,000	'
As Restated [Member]	'	'
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'
Net loss	($2,150,168)	($9,739,201)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:	'	'
Change in fair value of derivative	-137,344	-27,479
Gain on debt forgiveness	-11,757	'
Common Stock Issued In Exchange For Services	1,845,922	9,582,417
Amortization of debt discount	'	81,698
Beneficial conversion feature related to issuance of convertible debentures	20,000	'
Changes in assets and liabilities:	'	'
(Increase) Decrease in prepaid expense	53,750	-137,340
Increase (Decrease) in accounts payable	19,425	-16,210
Increase(Decrease) in accrued liabilities	36,270	37,500
Increase(Decrease) in Management fess	292,000	143,210
Increase(Decrease) in note payable to related parties	14,798	22,650
Increase(Decrease) in accrued interest	22,104	24,545
Net Cash Used in Operating Activities	5,000	-28,210
CASH FLOWS PROVIDED BY (USED FOR) INVESTING ACTIVITIES :	'	'
Net Cash Used in Investing Activities	'	'
CASH FLOWS FROM FINANCING ACTIVITIES:	'	'
Net Cash Provided by (Used for) Financing Activities	'	'
NET INCREASE (DECREASE) IN CASH	5,000	-28,210
CASH AT BEGINNING OF PERIOD	'	28,210
CASH AT END OF PERIOD	5,000	'
SUPPLEMENTAL CASH FLOW INFORMATION:	'	'
Cash Paid for interest	'	'
Cash Paid for taxes	'	'
Common Stock issued for services	1,845,922	9,582,417
Common Stock issued upon conversion	$44,000	$62,300

THE_COMPANY

THE COMPANY	6 Months Ended
	Sep. 30, 2013
Notes to Financial Statements	'
NOTE 1. THE COMPANY	'
	HISTORY
	InoLife Technologies, Inc. (the “Company”) was incorporated under the laws of the State of New York on November 12, 1998 as Safe Harbour Health Care Properties, Ltd. During 1999, the Company ceased its operations. The Company remained dormant until 2004, when one of the Company’s shareholders purchased a controlling interest. In February 2004, the Company began its development stage as an internet based marketing company. The Company, as of December 2007 discontinued its internet marketing due to difficulties with service providers and subsequent cancellations by customers.
	In August 2009, Gary Berthold purchased 35,013,540 shares of InoLife Technologies, Inc. representing a majority of the outstanding shares. In connection with the purchase, all of the directors and officers of the Company resigned from their positions, after first appointing Berthold as a director.
	Effective September 17, 2009, the Board of Directors of the Company authorized the execution of a share exchange agreement (the “Share Exchange Agreement”) with InoVet, Ltd., a Delaware corporation (“InoVet”) and the shareholders of InoVet (the “InoVet Shareholders”). In accordance with the terms and provisions of the Share Exchange Agreement, the Company agreed to: (i) acquire all of the issued and outstanding shares of common stock of InoVet from the InoVet Shareholders; and (ii) issue an aggregate of 10,000,000 shares of its restricted common stock to the InoVet Shareholders.
	On July 7, 2011, the Company acquired 100% of the issued and outstanding shares of Stemtide Inc. in exchange for 50,000,000 shares of common stock of the Company, the assumption of certain outstanding liabilities, and contingent residual payments of 10% of the gross profits derived from the sale of Stemtide Inc.’s Age-Reversing Products. The 50,000,000 shares of common stock were issued upon consummation of the agreement. The principal asset of Stemtide Inc. that was acquired was the manufacturing and marketing rights to the Stemtide Age-Reversing Products, throughout the United States, licensed from an affiliate of the principal shareholders of InoLife. These licensing rights were valued at $627,000 based on the Company assuming $572,000 of accounts payable and issuing 50,000,000 shares of common stock valued at $55,000. There were no other assets acquired. In addition, the Company issued 572 Series B PS as a securitization against the payment of the assumed accounts payable out of future revenues. The PS held as security will be reduced as the accounts payable are paid. The licensing rights were fully impaired at March 31, 2012.
	On February 23, 2012 the Company effected a 1 for 500 reverse stock split, and on January 24, 2013, the Company effected a 1 for 50,000 reverse stock split, collectively referred to as the Stock Splits. Unless otherwise noted, all impacted amounts included in the financial statements and notes thereto have been retroactively adjusted for the Stock Splits. Unless otherwise noted, impacted amounts include shares of common stock authorized and outstanding, share issuances and cancellations, shares underlying preferred stock, convertible notes, warrants and stock options, shares reserved, conversion prices of convertible securities, exercise prices of warrants and options, and loss per share.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Sep. 30, 2013
Notes to Financial Statements	'
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	Unaudited Interim Consolidated Financial Statements:
	The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States (“GAAP”) for complete consolidated financial statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals, unless otherwise indicated) considered necessary for a fair presentation of the interim financial data have been included. Operating results for the three and six months ended September 30, 2013 are not necessarily indicative of the results that may be expected for the fiscal year ending March 31, 2014. Events occurring subsequent to September 30, 2013 have been evaluated for potential recognition or disclosure in the unaudited consolidated financial statements for the three and six months ended September 30, 2013.
	The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes concerning the year ended March 31, 2013, which are included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2014, filed with the Securities and Exchange Commission (the “SEC”) on July 15, 2014.
	The condensed consolidated balance sheet at March 31, 2013 has been derived from the audited financial statements at that date, but does not include all of the information and footnotes required by generally accepted accounting principles in the U.S. for complete financial statements.
	The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Management believes that all adjustments necessary for a fair statement of the results of the three and six months ended September 30, 2013 and 2012 have been made.
	Significant Accounting Policies:
	Basis of Presentation:
	The Company prepares its consolidated financial statements on the accrual basis of accounting. All intercompany balances and transactions are eliminated.
	Cash and Cash Equivalents:
	All highly liquid investments with original maturities of three months or less are included in cash and cash equivalents. All deposits are maintained in FDIC insured depository accounts in local financial institutions and balances are insured up to $250,000.
	Fair Value Measurements:
	ASC Topic 820, “Fair Value Measurements and Disclosures”, defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and requires certain disclosures about fair value measurements. In general, fair value of financial instruments is based upon quoted market prices, where available. If such quoted market prices are not available, fair value is based upon internally developed models that primarily use, as inputs, observable market based parameters. Valuation adjustments may be made to ensure that financial instruments are recorded at fair value. These adjustments may include amounts to reflect counterparty credit quality and the Corporation’s credit worthiness, among other things, as well as unobservable parameters. Any such valuation adjustments are applied consistently over time.
	The carrying amount of cash and notes payable, as applicable, approximates fair value due to the short term nature of these items and/or the current interest rates payable in relation to current market conditions.
	Interest rate risk is the risk that the Company’s earnings are subject to fluctuations in interest rates on either investments or on debt and is fully dependent upon the volatility of these rates. The Company does not use derivative instruments to moderate its exposure to interest rate risk, if any.
	Financial risk is the risk that the Company’s earnings are subject to fluctuations in interest rates or foreign exchange rates and are fully dependent upon the volatility of these rates. The Company does not use derivative instruments to moderate its exposure to financial risk, if any.
	Earnings Per Share:
	Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share include the effects of any outstanding options, warrants and other potentially dilutive securities. Basic and diluted earnings per share (“EPS”) are based on weighted-average common shares and exclude shares that would have an anti-dilutive effect. The Company did not consider any potential common shares in the computation of diluted EPS as of September 30, 2013 and 2012, due to the loss from continuing operations, as they would have an anti-dilutive effect on EPS.
	Share Based Payments:
	The Company accounts for share based payments using a fair value based method whereby compensation cost is measured at the grant date based on the value of the services received and is recognized over the service period. The Company uses the Black-Scholes pricing model to calculate the fair value of options and warrants issued. In calculating this fair value, there are certain assumptions used such as the expected life of the option, risk-free interest rate, dividend yield, volatility and forfeiture rate. The use of a different estimate for any one of these components could have a material impact on the amount of calculated compensation expense.
	Segment Reporting
	The Company has determined it has only one operating segment as of the periods presented.
	Income Taxes
	The Company accounts for income taxes under ASC 740 Income Taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. The Company has had significant operating losses and a valuation allowance is recorded for the entire amount of the deferred tax assets, resulting in no deferred tax assets or liabilities recognized as of September 30, 2013 or September 30, 2012.
	The Company accounts for uncertain tax positions according to the provisions of ASC 740. ASC 740 contains a two-step approach for recognizing and measuring uncertain tax positions. Tax positions are evaluated for recognition by determining if the weight of available evidence indicates that it is probable that the position will be sustained on audit, including resolution of related appeals or litigation. Tax benefits are then measured as the largest amount which is more than 50% likely of being realized upon ultimate settlement. The Company considers many factors when evaluating and estimating tax positions and tax benefits, which may require periodic adjustments and which may not accurately anticipate actual outcomes.
	The Company’s open tax periods are 2009 through 2013.
	Recently Issued Accounting Pronouncements:
	On June 10, 2014 the FASB issued ASU No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The amendments in this ASU remove all incremental financial reporting requirements from U.S. GAAP for development stage entities. The Company has elected to early adopt this guidance, and therefore is no longer presenting the financial statements in accordance with ASU 915, with inception to date disclosures.
	The Company is evaluating how to apply ASU 605, Revenues from Contracts with Customers, before its effective date, however, as the Company does not yet have revenue to recognize, it will not have an impact on current results of operations, financial position or cash flow.

CONVERTIBLE_NOTES_PAYABLE

CONVERTIBLE NOTES PAYABLE	6 Months Ended
	Sep. 30, 2013
Notes to Financial Statements	'
NOTE 3. CONVERTIBLE NOTES PAYABLE	'
	Convertible notes payable consist of the following at September 30, 2013 and March 31, 2013:
		Due Date			Interest				30-Sep-13		March 31,
											2013
	E-Lionheart	2/3/12				8	%			203,960		203,960
	Longside Ventures	various				various				269,267		269,267
	Orchid	5/12/12				0	%			37,600		37,600
	Just Marketing	Demand				10	%			40,000		-
	New Opportunity Business Solutions	Demand				10	%			26,800		27,500
	Robin W. Hunt	Demand				10	%			13,707		57,915
										591,334		596,242
	Debt Discount									-		10,412
										591,334		585,830
	The Company has evaluated their convertible notes for embedded derivative features and has determined that in several of the notes a derivative liability is necessary to recognize. These notes contain a conversion feature which includes a “reset” provision, whereby the conversion rate would be reset should there be future equity sales at a price less than the conversion rate in effect at the time. Therefore, the conversion feature is required to be bifurcated and accounted for under derivative accounting, and remeasured each period end, with any changes in the fair value of the derivative to be recognized in income. All the notes which contained the reset provision were entered into during the year ended March 31, 2012. The original fair value of the derivative liability at inception totaled $456,719. During the six months ended September 30, 2013 and 2012, a change in fair value of $137,344 and $27,479, respectively, was recognized. There was no change in fair value in the three months ended December 31, 2013 and a $27,479 change in fair value in the three months ended September 30, 2012. . During the three months ended June 30, 2013 there was a reduction in the derivative liability of $137,344 due to the reduction of the related notes principal balances, which was recognized as a separate line item on the accompanying Statement of Operations. The fair value of the derivative liability as of both September 30, 2013 and March 31, 2013, , has been determined to be $228,000. Derivative liabilities were valued using a probability based weighted-average Black-Scholes-Merton valuation with the following assumptions:
		September 30,				31-Mar
		2013				2013
	Risk-free interest rate		0.03	%			0.03	%
	Expected volatility		100	%			100	%
	Expected life (in years)		Remaining term				Remaining term
	Expected dividend yield		0	%			0	%
	The conversion features were evaluated for any beneficial aspect and it was determined that several of the notes contained beneficial conversion features, whereby the conversion rate was calculated at a discount to the market price. The beneficial conversion features recognized at inception during the year ended March 31, 2012 amounted to $234,000. The discount related to the beneficial conversion features as well as the discount arising from the derivative liability was amortized over the term of the related convertible debentures using the effective interest method, resulting in amortization of approximately $10,000, and $109,000 during the six months ended September 30, 2013 and 2012, respectively.
	On July 23, 2013, the Company entered into a $40,000 convertible debenture with Just Marketing,Group, Inc., which bears interest at 10%. The note is due on demand 120 days after issuance. The note is convertible, beginning 60 days after issuance, at a 50% discount to market price on date of conversion, or mutually agreed upon terms. The Company determined the conversion feature was not required to be bifurcated, as although the conversion terms were not fixed, we do not know what mutually agreed upon terms will be and if will not still qualify as indexed to the Company’s own stock. Therefore, the Company recognized a beneficial conversion feature in the amount of $20,000. The related debt discount was amortized over the 120 day period until demand, which has been considered the maturity date.
	At September 30, 2013 and March 31, 2013 the accrued interest on all notes is $74,300 and $63,000, respectively.
	During the three and six months ended September 30, 2013, the Company issued an aggregate of 8,000,000 and 32,000,000, shares of its common stock, respectively, to note holders pursuant to the original terms of the Convertible Debentures, representing the conversion of $16,000 and $44,000, respectively in principal and accrued interest.

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Sep. 30, 2013
Notes to Financial Statements	'
NOTE 4. RELATED PARTY TRANSACTIONS	'
	During July 2012 the Company issued three billion shares of common stock to its Officers for past services rendered with a fair value of $9,000,000, based on the market price of the stock on the date granted. These shares were subsequently cancelled on November 27, 2012 and replaced by 120,000 shares of preferred stock with a fair value of $300,000.

COMMON_AND_PREFERRED_STOCK

COMMON AND PREFERRED STOCK	6 Months Ended
	Sep. 30, 2013
Notes to Financial Statements	'
NOTE 5. COMMON AND PREFERRED STOCK	'
	Please see Note 3 for all share issuances upon conversions of convertible debentures.
	Please see Note 4 for a discussion of common and Preferred Stock issued to related parties. As of September 30, 2013, all the Preferred Stock of the Company is held by the Officers.
	On May 1, 2013, INOL entered into an Exclusive Licensing Agreement with Green Dolphin Corp, whose President has agreed to become VP of Business Development. In connection with the license agreement the Company issued to Green Dolphin 1,200,000 common shares, with a fair value based on the market price of the shares of $264,000 (amount included in disclosure above). As the shares were issued to a company controlled by a consultant of the Company, and it is not known if the Company will ever actually distribute the products offered under the license agreement, the shares have been treated as additional compensation to the consultant.
	During the three and six months ended September 30, 2013 the Company issued 260,000 and 18,040,000 shares of its common stock for services to various consultants with a fair value of $1,845,922. The fair value was determined using the market price of the Company’s stock on the date of issuance.

FINANCIAL_CONDITION_AND_GOING_

FINANCIAL CONDITION AND GOING CONCERN	6 Months Ended
	Sep. 30, 2013
Notes to Financial Statements	'
NOTE 6. FINANCIAL CONDITION AND GOING CONCERN	'
	The Company has minimal operations and has negative working capital as of September 30, 2013. Due to the limited operating history and limited operations, the Company will require additional working capital to survive. If the funds the Company has are not sufficient, it will also consider bank loans and additional shareholder loans. There are no assurances that the Company will be able to obtain any of these. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital cannot be generated, the Company may not be able to continue its operations.
	These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might be necessary should the Company be able to continue as a going concern.

RESTATEMENT

RESTATEMENT	6 Months Ended
	Sep. 30, 2013
Notes to Financial Statements	'
NOTE 7. RESTATEMENT	'
	As noted previously, the Company filed the interim consolidated financial statements without review by an independent public accountant. Additionally the Company did not have a permanent CFO or accounting personnel. As the accompanying consolidated financial statements were prepared for review in this amended filing, it was noted that there were several clerical errors, and the financial statements as originally filed did not agree to the Company’s accounting records. Therefore, a portion of the restatement cannot be identified as due to certain transactions which were incorrectly recognized in the original financial statements. A majority of the difference between the financial statements as originally filed and included herein can be attributed to previous period’s restatements, as disclosed in the Form 10K for the years ended March 31, 2014 and 2013, and their impact going forward. These restatement entries have been identified below, with the remaining differences attributed to clerical error.
	The Company identified errors are as follows:
	Through March 31, 2013
	In connection with several of the Convertible Notes payable entered into during the year ended March 31, 2012, the embedded derivative was not appropriately evaluated and certain “reset” provisions was not properly bifurcated and accounted for under derivative accounting. The derivative liability connected to these Convertible Notes Payable amounted to $456,719 at inception, with a change to the derivative fair value of $77,788 for the year ended March 31, 2012 and $13,444 for the year ended March 31, 2013.
	In connection with several of the Convertible Notes payable entered into during the year ended March 31, 2012, the conversion feature was not appropriately evaluated to recognize a beneficial conversion feature upon issuance. The beneficial conversion features amounted to $234,000 at inception, with $$148,500 of the resulting debt discount being amortized during the year ended March 31, 2012 and $85,500 amortized during March 31, 2013.
	On April 18, 2012, the Company issued 30,000,000 common shares in satisfaction of $465,000 of accrued compensation to Gary and Sharon Berthold. The amount was incorrectly recognized as $226,500 in APIC. Additionally, in connection with a swap of Preferred Stock, $71,700 was incorrectly recognized in APIC.
	During the year ended March 31, 2013, certain shares issued in connection with a consulting agreement were incorrectly valued at $1,000 based on the par value of the shares. The corrected fair value of the shares issued for services was $90,000, based on the market price of the shares. Additionally, one consulting agreement was omitted in error.
	In connection with the acquisition of Stemtide, 572 Series C Preferred Shares were issued as securitization for the future payment of the accounts payable of Stemtide assumed in the acquisition. These shares were incorrectly accounted for as if issued in satisfaction of the accounts payable
	During the year ended March 31, 2013 the Company extinguished several Convertible Debentures, in the amount of $550,845 including accrued interest, without formal agreements for the forgiveness of debt.
	Through September 3, 2013
	Certain shares issued to consultants and directors were incorrectly valued at par, and have been restated to recognize the fair value of the shares issued.
	The derivative liability (which had not been recognized on the original financial statements) was remeasured as of the end of the period, with the change in fair value recognized in earnings.
	During the six months ended September 30, 2013 the Company extinguished several Convertible Debentures and accounts payable, in the amount of approximately $333,000 including accrued interest, without formal agreements for the forgiveness of debt. These amounts were reinstated, with interest for the six months ending September 30, 2013 being properly accrued.
	INOLIFE TECHNOLOGIES, INC.
	Balance Sheets
			30-Sep-13		Derivative Liability at Inception		Deriviative Liability - Change in Fair Value - March 31, 2013		Amortization of Discount related to derivative - March 31, 2013		BCF at Inception		BCF Amortization during 2012		BCF Amortization during 2013		Shares issued to Officers for compensation	Consulting agreements March 31, 2013		PS Series B 2012		Extinguishment of Debt March 31, 2013		Miscellaneous adjustments as of March 31, 2013		Deriviative Liability - Change in Fair Value - June 30, 2013		Extinguishment of Debt September 30, 2013	Interest on Notes Payable reinstated		Consulting agreements		Clerical errors	30-Sep-13
			As originally reported																															As Restated
																											ASSETS
	Current Assets
	Cash and cash equivalents		$	5,000																																										$	5,000
	Prepaid Expenses			-																																											-
	Total Current Assets			5,000																																											5,000
	TOTAL ASSETS		$	5,000																																										$	5,000
	LIABILITIES AND STOCKHOLDERS' DEFICIT
	Current Liabilities
	Accounts payable		$	-																									572,000					61,465				59,944						94,266		$	787,675
	Accrued management fees, related party			593,857																				(48,648	)																			118,876			664,085
	Accrued consulting fees			-																							62,500															(40,000	)	5,200			27,700
	Accrued employer taxes			214,389																				70,230																				(189,106	)		95,513
	Accrued interest			756																												136,786								31,105							168,647
	Convertible notes payable			-			(159,292	)					148,881			(234,000	)	148,500			85,500											456,530						145,216									591,335
	Derivative Liability			-			456,719			(91,375	)																									(137,344	)										228,000
	Note payable, related party			-																																		78,958									78,959
	Total Current Liabilities			809,002																																											2,641,913
	TOTAL LIABILITIES			809,002																																											2,641,913
	COMMITMENTS AND CONTINGENCIES
	Stockholders' Deficit
	Preferred stock:									-
	Preferred Stock - Series B			2																																											2
	Preferred Stock - Series C			6																																											6
	Common stock:			2,883																																								(2,772	)		1,485
	Shares held in escrow			-																																											-
	Additional paid in capital			6,614,298			180,186									234,000								(71,700	)		89,000		(572,000	)								49,000				749,350		(26,150	)		7,244,610
	Accumulated deficit			(7,421,191	)		(477,613	)		91,375			(148,881	)				(148,500	)		(85,500	)		50,118			(151,500	)				(593,316	)	(61,465	)	137,344		(333,118	)	(31,105	)	(709,350	)	(315	)		(9,883,016	)
	Total Stockholders' Deficit			(804,002	)																																										(2,636,913	)
	TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT		$	5,000																																										$	5,000
	Total Stockholders' Deficit
	INOLIFE TECHNOLOGIES, INC.
	Consolidated Statements of Operations
				September 30,				Deriviative Liability - Change				Amortization of Discount related				Consulting			Miscellaneous				September 30,
				2012				in Fair Value				to derivative				agreements			adjustments				2012
					As originally reported																			As
																								Restated
	Revenues			$	-																			-
	Operating Expenses
		Professional fees			9,602,526												37,500			(9,466,924	)			173,102
		Managment expenses																		9,446,835				9,446,835
		Selling, general and administrative expense			45,240															(3,644	)			41,595
		Total operating expenses			9,647,766																			9,661,532
	Net loss from operations				(9,647,766	)																		(9,661,532	)
	Other income (expense)
		Interest expense			(27,833	)							(36,698	)						(40,617	)			(105,148	)
		Gain on debt forgiveness			-																			-
	Miscellaneous expense			-																			-
	Change in fair value of derivative			-				27,479															27,479
				(27,833	)																		(77,669	)
	Loss before provision for taxes			(9,675,599	)																		(9,739,201	)
	Provision for income taxes			-																			-
Net loss			$	(9,675,599	)																		(9,739,201	)
Basic and diluted loss per share			$	(21,266	)																		(21,406	)
Weighted average number of shares outstanding				455																			455

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Sep. 30, 2013
Notes to Financial Statements	'
NOTE 8. SUBSEQUENT EVENTS	'
	Management has evaluated all activity of the Company through January 9, 2014 (the original issue date of the financial statements) and concluded that the following additional subsequent events have occurred that require recognition in the financial statements or disclosure in the notes to financial statements.
	On Oct 18, 2013 the Company increased the authorized shares from 250,000,000 to 400,000,000 shares.
	On November 29, 2013 Sharon Berthold resigned her positions as Executive Vice President, Director and Secretary.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Sep. 30, 2013
Summary Of Significant Accounting Policies Policies	'
Basis of Presentation	'
	The Company prepares its consolidated financial statements on the accrual basis of accounting. All intercompany balances and transactions are eliminated.
Cash and Cash Equivalents	'
	All highly liquid investments with original maturities of three months or less are included in cash and cash equivalents. All deposits are maintained in FDIC insured depository accounts in local financial institutions and balances are insured up to $250,000.
Fair Value Measurements	'
	ASC Topic 820, “Fair Value Measurements and Disclosures”, defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and requires certain disclosures about fair value measurements. In general, fair value of financial instruments is based upon quoted market prices, where available. If such quoted market prices are not available, fair value is based upon internally developed models that primarily use, as inputs, observable market based parameters. Valuation adjustments may be made to ensure that financial instruments are recorded at fair value. These adjustments may include amounts to reflect counterparty credit quality and the Corporation’s credit worthiness, among other things, as well as unobservable parameters. Any such valuation adjustments are applied consistently over time.
	The carrying amount of cash and notes payable, as applicable, approximates fair value due to the short term nature of these items and/or the current interest rates payable in relation to current market conditions.
	Interest rate risk is the risk that the Company’s earnings are subject to fluctuations in interest rates on either investments or on debt and is fully dependent upon the volatility of these rates. The Company does not use derivative instruments to moderate its exposure to interest rate risk, if any.
	Financial risk is the risk that the Company’s earnings are subject to fluctuations in interest rates or foreign exchange rates and are fully dependent upon the volatility of these rates. The Company does not use derivative instruments to moderate its exposure to financial risk, if any.
Earnings Per Share	'
	Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share include the effects of any outstanding options, warrants and other potentially dilutive securities. Basic and diluted earnings per share (“EPS”) are based on weighted-average common shares and exclude shares that would have an anti-dilutive effect. The Company did not consider any potential common shares in the computation of diluted EPS as of September 30, 2013 and 2012, due to the loss from continuing operations, as they would have an anti-dilutive effect on EPS.
Share Based Payments	'
	The Company accounts for share based payments using a fair value based method whereby compensation cost is measured at the grant date based on the value of the services received and is recognized over the service period. The Company uses the Black-Scholes pricing model to calculate the fair value of options and warrants issued. In calculating this fair value, there are certain assumptions used such as the expected life of the option, risk-free interest rate, dividend yield, volatility and forfeiture rate. The use of a different estimate for any one of these components could have a material impact on the amount of calculated compensation expense.
Segment Reporting	'
	The Company has determined it has only one operating segment as of the periods presented.
Income Taxes	'
	The Company accounts for income taxes under ASC 740 Income Taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. The Company has had significant operating losses and a valuation allowance is recorded for the entire amount of the deferred tax assets, resulting in no deferred tax assets or liabilities recognized as of September 30, 2013 or September 30, 2012.
	The Company accounts for uncertain tax positions according to the provisions of ASC 740. ASC 740 contains a two-step approach for recognizing and measuring uncertain tax positions. Tax positions are evaluated for recognition by determining if the weight of available evidence indicates that it is probable that the position will be sustained on audit, including resolution of related appeals or litigation. Tax benefits are then measured as the largest amount which is more than 50% likely of being realized upon ultimate settlement. The Company considers many factors when evaluating and estimating tax positions and tax benefits, which may require periodic adjustments and which may not accurately anticipate actual outcomes.
	The Company’s open tax periods are 2009 through 2013.
Recently Issued Accounting Pronouncements	'
	On June 10, 2014 the FASB issued ASU No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The amendments in this ASU remove all incremental financial reporting requirements from U.S. GAAP for development stage entities. The Company has elected to early adopt this guidance, and therefore is no longer presenting the financial statements in accordance with ASU 915, with inception to date disclosures.
	The Company is evaluating how to apply ASU 605, Revenues from Contracts with Customers, before its effective date, however, as the Company does not yet have revenue to recognize, it will not have an impact on current results of operations, financial position or cash flow.

CONVERTIBLE_NOTES_PAYABLE_Tabl

CONVERTIBLE NOTES PAYABLE (Tables)	6 Months Ended
	Sep. 30, 2013
Convertible Notes Payable Tables	'
Convertible notes payable	'
	Convertible notes payable consist of the following at September 30, 2013 and March 31, 2013:
		Due Date			Interest				30-Sep-13		March 31,
											2013
	E-Lionheart	2/3/12				8	%			203,960		203,960
	Longside Ventures	various				various				269,267		269,267
	Orchid	5/12/12				0	%			37,600		37,600
	Just Marketing	Demand				10	%			40,000		-
	New Opportunity Business Solutions	Demand				10	%			26,800		27,500
	Robin W. Hunt	Demand				10	%			13,707		57,915
										591,334		596,242
	Debt Discount									-		10,412
										591,334		585,830
Derivative liabilities	'
	Derivative liabilities were valued using a probability based weighted-average Black-Scholes-Merton valuation with the following assumptions:
		September 30,				31-Mar
		2013				2013
	Risk-free interest rate		0.03	%			0.03	%
	Expected volatility		100	%			100	%
	Expected life (in years)		Remaining term				Remaining term
	Expected dividend yield		0	%			0	%

RESTATEMENT_Tables

RESTATEMENT (Tables)	6 Months Ended
	Sep. 30, 2013
Restatement Tables	'
Restated Consolidated Balance Sheets	'
	INOLIFE TECHNOLOGIES, INC.
	Balance Sheets
			30-Sep-13		Derivative Liability at Inception		Deriviative Liability - Change in Fair Value - March 31, 2013		Amortization of Discount related to derivative - March 31, 2013		BCF at Inception		BCF Amortization during 2012		BCF Amortization during 2013		Shares issued to Officers for compensation	Consulting agreements March 31, 2013		PS Series B 2012		Extinguishment of Debt March 31, 2013		Miscellaneous adjustments as of March 31, 2013		Deriviative Liability - Change in Fair Value - June 30, 2013		Extinguishment of Debt September 30, 2013	Interest on Notes Payable reinstated		Consulting agreements		Clerical errors	30-Sep-13
			As originally reported																															As Restated
																											ASSETS
	Current Assets
	Cash and cash equivalents		$	5,000																																										$	5,000
	Prepaid Expenses			-																																											-
	Total Current Assets			5,000																																											5,000
	TOTAL ASSETS		$	5,000																																										$	5,000
	LIABILITIES AND STOCKHOLDERS' DEFICIT
	Current Liabilities
	Accounts payable		$	-																									572,000					61,465				59,944						94,266		$	787,675
	Accrued management fees, related party			593,857																				(48,648	)																			118,876			664,085
	Accrued consulting fees			-																							62,500															(40,000	)	5,200			27,700
	Accrued employer taxes			214,389																				70,230																				(189,106	)		95,513
	Accrued interest			756																												136,786								31,105							168,647
	Convertible notes payable			-			(159,292	)					148,881			(234,000	)	148,500			85,500											456,530						145,216									591,335
	Derivative Liability			-			456,719			(91,375	)																									(137,344	)										228,000
	Note payable, related party			-																																		78,958									78,959
	Total Current Liabilities			809,002																																											2,641,913
	TOTAL LIABILITIES			809,002																																											2,641,913
	COMMITMENTS AND CONTINGENCIES
	Stockholders' Deficit
	Preferred stock:									-
	Preferred Stock - Series B			2																																											2
	Preferred Stock - Series C			6																																											6
	Common stock:			2,883																																								(2,772	)		1,485
	Shares held in escrow			-																																											-
	Additional paid in capital			6,614,298			180,186									234,000								(71,700	)		89,000		(572,000	)								49,000				749,350		(26,150	)		7,244,610
	Accumulated deficit			(7,421,191	)		(477,613	)		91,375			(148,881	)				(148,500	)		(85,500	)		50,118			(151,500	)				(593,316	)	(61,465	)	137,344		(333,118	)	(31,105	)	(709,350	)	(315	)		(9,883,016	)
	Total Stockholders' Deficit			(804,002	)																																										(2,636,913	)
	TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT		$	5,000																																										$	5,000
	Total Stockholders' Deficit
Restated Consolidated Statements of Operations	'
	INOLIFE TECHNOLOGIES, INC.
	Consolidated Statements of Operations
				September 30,				Deriviative Liability - Change				Amortization of Discount related				Consulting			Miscellaneous				September 30,
				2012				in Fair Value				to derivative				agreements			adjustments				2012
					As originally reported																			As
																								Restated
	Revenues			$	-																			-
	Operating Expenses
		Professional fees			9,602,526												37,500			(9,466,924	)			173,102
		Managment expenses																		9,446,835				9,446,835
		Selling, general and administrative expense			45,240															(3,644	)			41,595
		Total operating expenses			9,647,766																			9,661,532
	Net loss from operations				(9,647,766	)																		(9,661,532	)
	Other income (expense)
		Interest expense			(27,833	)							(36,698	)						(40,617	)			(105,148	)
		Gain on debt forgiveness			-																			-
		Miscellaneous expense			-																			-
		Change in fair value of derivative			-				27,479															27,479
					(27,833	)																		(77,669	)
		Loss before provision for taxes			(9,675,599	)																		(9,739,201	)
		Provision for income taxes			-																			-
	Net loss			$	(9,675,599	)																		(9,739,201	)
	Basic and diluted loss per share			$	(21,266	)																		(21,406	)
	Weighted average number of shares outstanding				455																			455

CONVERTIBLE_NOTES_PAYABLE_Deta

CONVERTIBLE NOTES PAYABLE (Details) (USD $)	6 Months Ended
	Sep. 30, 2013	Mar. 31, 2013
Convertible notes payable	$591,334	$596,242
Debt Discount	'	10,412
Convertible notes payable, Net	591,334	585,830
E-Lionheart [Member]	'	'
Due Date	3-Feb-12	'
Interest, Percentage	8.00%	'
Convertible notes payable	203,960	203,960
Longside Ventures [Member]	'	'
Due Date	'various	'
Interest	'various	'
Convertible notes payable	269,267	269,267
Orchid [Member]	'	'
Due Date	12-May-12	'
Interest, Percentage	0.00%	'
Convertible notes payable	37,600	37,600
Just Marketing [Member]	'	'
Due Date	'Demand	'
Interest, Percentage	10.00%	'
Convertible notes payable	40,000	'
New Opportunity Business Solutions [Member]	'	'
Due Date	'Demand	'
Interest, Percentage	10.00%	'
Convertible notes payable	26,800	27,500
Robin W. Hunt [Member]	'	'
Due Date	'Demand	'
Interest, Percentage	10.00%	'
Convertible notes payable	$13,707	$57,915

CONVERTIBLE_NOTES_PAYABLE_Deta1

CONVERTIBLE NOTES PAYABLE (Details 1)	6 Months Ended	12 Months Ended
	Sep. 30, 2013	Mar. 31, 2013
Convertible Notes Payable Details 1	'	'
Risk-free interest rate	0.03%	0.03%
Expected volatility	100.00%	100.00%
Expected life (in years)	'Remaining term	'Remaining term
Expected dividend yield	0.00%	0.00%

CONVERTIBLE_NOTES_PAYABLE_Deta2

CONVERTIBLE NOTES PAYABLE (Details Narrative) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Mar. 31, 2012	Mar. 31, 2013
Convertible Notes Payable Details Narrative	'	'	'	'	'	'
Change in fair value of derivative liability	$0	$27,479	$137,344	$27,479	'	'
Fair value of the derivative liability	228,000	'	228,000	'	'	228,000
Beneficial conversion features recognized	'	'	'	'	234,000	'
Derivative liability amortization	'	'	10,000	109,000	'	'
Accrued interest	74,300	'	74,300	'	'	63,000
Common stock shares issued	8,000,000	'	32,000,000	'	'	'
Convertible debentures conversion	$16,000	'	$16,000	'	'	$44,000

COMMON_AND_PREFERRED_STOCK_Det

COMMON AND PREFERRED STOCK (Details Narrative) (USD $)	3 Months Ended	6 Months Ended
	Sep. 30, 2013	Sep. 30, 2013
Common And Preferred Stock Details Narrative	'	'
Common stock for services to various consultants, Amount	'	$1,845,922
Common stock for services to various consultants, Shares	260,000	18,040,000

RESTATEMENT_Details

RESTATEMENT (Details) (USD $)

Mar. 31, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

As originally reported [Member]

Derivative Liability at Inception [Member]

Deriviative Liability - Change in Fair Value - March 31, 2013 [Member]

Amortization of Discount related to derivative - March 31, 2013 [Member]

BCF at Inception [Member]

BCF Amortization during 2012 [Member]

BCF Amortization during 2013 [Member]

Shares issued to Officers for compensation [Member]

Consulting agreements March 31, 2013 [Member]

PS Series B 2012 [Member]

Extinguishment of Debt March 31, 2013 [Member]

Miscellaneous adjustments as of March 31, 2013 [Member]

Deriviative Liability - Change in Fair Value - June 30, 2013 [Member]

Extinguishment of Debt September 30, 2013 [Member]

Interest on Notes Payable reinstated [Member]

Consulting agreements [Member]

Clerical errors [Member]

As Restated [Member]

Current Assets:

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash and cash equivalents

'

$5,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$5,000

Prepaid Expenses

53,750

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total Current Assets

53,750

5,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,000

TOTAL ASSETS

53,750

5,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,000

Current Liabilities:

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accounts payable

766,640

'

'

'

'

'

'

'

'

'

572,000

'

61,465

'

59,944

'

'

94,266

787,675

Accrued management fees, related party

372,085

593,857

'

'

'

'

'

'

-48,648

'

'

'

'

'

'

'

'

118,876

664,085

Accrued consulting fees

62,500

'

'

'

'

'

'

'

'

62,500

'

'

'

'

'

'

-40,000

5,200

27,700

Accrued employer taxes

84,442

214,389

'

'

'

'

'

'

70,230

'

'

'

'

'

'

'

'

-189,106

95,513

Accrued interest

146,543

756

'

'

'

'

'

'

'

'

'

136,786

'

'

'

31,105

'

'

168,647

Convertible notes payable

585,830

'

-159,292

'

148,881

-234,000

148,500

85,500

'

'

'

456,530

'

'

145,216

'

'

'

591,335

Derivative Liability

365,344

'

456,719

-91,375

'

'

'

'

'

'

'

'

'

-137,344

'

'

'

'

228,000

Notes payable - related party

64,161

'

'

'

'

'

'

'

'

'

'

'

'

'

78,958

'

'

'

78,958

Total Current Liabilities

2,447,545

809,002

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,641,913

TOTAL LIABILITIES

2,447,545

809,002

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,641,913

Commitments and Contingencies

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stockholders' Deficit

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock:

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2

Preferred Stock - Series B

'

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2

Preferred Stock - Series C

6

6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6

Common stock:

400

2,883

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-2,772

1,485

Shares held in escrow

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Additional paid in capital

5,338,645

6,614,298

180,186

'

'

234,000

'

'

-71,700

89,000

-572,000

'

'

'

49,000

'

749,350

-26,150

7,244,610

Accumulated deficit

-7,732,848

-7,421,191

-477,613

91,375

-148,881

'

-148,500

-85,500

50,118

-151,500

'

-593,316

-61,465

137,344

-333,118

-31,105

-709,350

-315

-9,883,016

Total Shareholders' Deficit

-2,393,795

-804,002

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-2,636,913

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT

$53,750

$5,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$5,000

RESTATEMENT_Details_1

RESTATEMENT (Details 1) (USD $)	3 Months Ended		6 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
As originally reported [Member]	'	'	'	'
Revenues	'	'	'	'
Operating Expenses	'	'	'	'
Professional fees	'	'	'	9,602,526
Selling, general and administrative expense	'	'	'	45,240
Total operating expenses	'	'	'	9,647,766
Net loss from operations	'	'	'	-9,647,766
Other income (expenses)	'	'	'	'
Interest expense	'	'	'	-27,833
Gain on debt forgiveness	'	'	'	'
Miscellaneous expense	'	'	'	'
Change in fair value of derivative	'	'	'	'
Total other income (expenses)	'	'	'	-27,833
Loss before provision for taxes	'	'	'	-9,675,599
Provision for income taxes	'	'	'	'
Net loss	'	'	'	-9,675,599
Basic and diluted loss per share	'	'	'	($21,266)
Weighted average number of shares outstanding	'	'	'	455
Deriviative Liability - Change in Fair Value [Member]	'	'	'	'
Other income (expenses)	'	'	'	'
Change in fair value of derivative	'	'	'	27,479
Miscellaneous adjustments [Member]	'	'	'	'
Other income (expenses)	'	'	'	'
Interest expense	'	'	'	-36,698
Amortization of Discount related to derivative [Member]	'	'	'	'
Operating Expenses	'	'	'	'
Professional fees	'	'	'	37,500
Consulting agreements [Member]	'	'	'	'
Operating Expenses	'	'	'	'
Professional fees	'	'	'	-9,466,924
Managment expenses	'	'	'	9,446,835
Selling, general and administrative expense	'	'	'	-3,644
Other income (expenses)	'	'	'	'
Interest expense	'	'	'	-40,617
As Restated [Member]	'	'	'	'
Revenues	'	'	'	'
Operating Expenses	'	'	'	'
Professional fees	24,095	147,458	1,924,902	173,102
Managment expenses	'	'	'	9,446,835
Selling, general and administrative expense	8,282	17,543	37,751	41,595
Total operating expenses	178,377	9,365,869	2,254,653	9,661,532
Net loss from operations	-178,377	-9,365,869	-2,254,653	-9,661,532
Other income (expenses)	'	'	'	'
Interest expense	-35,902	-47,957	-58,827	-105,148
Gain on debt forgiveness	'	'	11,757	'
Miscellaneous expense	'	'	'	'
Change in fair value of derivative	'	27,479	137,344	27,479
Total other income (expenses)	-21,691	-20,478	104,485	-77,669
Loss before provision for taxes	-200,068	-9,386,347	-2,150,168	-9,739,201
Provision for income taxes	'	'	'	'
Net loss	($200,068)	($9,386,347)	($2,150,168)	($9,739,201)
Basic and diluted loss per share	'	'	'	($21,406)
Weighted average number of shares outstanding	'	'	'	455

RESTATEMENT_Details_Narrative

RESTATEMENT (Details Narrative) (USD $)	6 Months Ended	12 Months Ended
	Sep. 30, 2013	Mar. 31, 2013
Restatement Details Narrative	'	'
Convertible Debentures and accounts payable	$333,000	$550,845